Fri, January 22, 2021

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $40 on, Jan 22nd, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $33 to $40 on, Jan 22nd, 2021.

Raghuram has made no other calls on SPRO in the last 4 months.



There are 2 other peers that have a rating on SPRO. Out of the 2 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $47 on, Wednesday, December 16th, 2020
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020